Search by Drug Name or NDC
NDC 54257-0858-02 Extraprin 250; 250; 65 mg/1; mg/1; mg/1 Details
Extraprin 250; 250; 65 mg/1; mg/1; mg/1
Extraprin is a ORAL TABLET in the HUMAN OTC DRUG category. It is labeled and distributed by Magno-Humphries, Inc.. The primary component is ACETAMINOPHEN; ASPIRIN; CAFFEINE.
Product Information
| NDC | 54257-0858 |
|---|---|
| Product ID | 54257-858_08bf8c82-76d4-440e-e063-6294a90af3d3 |
| Associated GPIs | |
| GCN Sequence Number | 040186 |
| GCN Sequence Number Description | aspirin/acetaminophen/caffeine TABLET 250-250-65 ORAL |
| HIC3 | H3D |
| HIC3 Description | ANALGESIC/ANTIPYRETICS, SALICYLATES |
| GCN | 10414 |
| HICL Sequence Number | 001807 |
| HICL Sequence Number Description | ASPIRIN/ACETAMINOPHEN/CAFFEINE |
| Brand/Generic | Generic |
| Proprietary Name | Extraprin |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | ACETAMINOPHEN, ASPIRIN, CAFFEINE |
| Product Type | HUMAN OTC DRUG |
| Dosage Form | TABLET |
| Route | ORAL |
| Active Ingredient Strength | 250; 250; 65 |
| Active Ingredient Units | mg/1; mg/1; mg/1 |
| Substance Name | ACETAMINOPHEN; ASPIRIN; CAFFEINE |
| Labeler Name | Magno-Humphries, Inc. |
| Pharmaceutical Class | Anti-Inflammatory Agents, Non-Steroidal [CS], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Methylxanthine [E |
| DEA Schedule | n/a |
| Marketing Category | OTC MONOGRAPH DRUG |
| Application Number | M013 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 54257-0858-02 (54257085802)
| NDC Package Code | 54257-858-02 |
|---|---|
| Billing NDC | 54257085802 |
| Package | 100 TABLET in 1 BOTTLE (54257-858-02) |
| Marketing Start Date | 2020-01-24 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |